These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 653)

  • 1. [Zollinger-Ellison syndrome treated medically by an inhibitor of H2 histamine receptors].
    Bonfils S; Bernier JJ; Mignon M; Hautefeuille P; Corbic M; Marteau J
    Nouv Presse Med; 1975 Oct; 4(33):2377-81. PubMed ID: 653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome.
    Richardson CT; Walsh JH
    N Engl J Med; 1976 Jan; 294(3):133-5. PubMed ID: 616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
    Bonfils S; Bernier JJ; Mignon M; Lambert R; Bernades P; L'Hirondel C; Accary JP; Kloeti G
    Digestion; 1977; 15(1):43-52. PubMed ID: 838177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
    Lamers CB; Festen HP; van Tongeren JH
    Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists].
    Lamers CB
    Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome].
    Mignon M; Galmiche JP; Bonfils S
    Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of metiamide in the preoperative management of the Zollinger-El.
    Smith ER; Cuthbert JA; McKessar JH; Francis PN; Little JM
    Med J Aust; 1976 Jun; 1(26):1000-1. PubMed ID: 979765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter: Treatment of Zollinger-Ellison syndromes with metiamide or cimetidine. Potential risk of hyperimmunization manifestations].
    Moulias R; Congy F
    Nouv Presse Med; 1976 Jan; 5(3):149-50. PubMed ID: 4772
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: H2-receptor antagonists for Z-E syndrome.
    Shumaker JB
    N Engl J Med; 1976 Apr; 294(18):1010-11. PubMed ID: 1256502
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with H2 receptor antagonists. Zollinger-Ellison Syndrome.
    Siepler JK; Donahue P; Campagna K; Bombeck CT
    IMJ Ill Med J; 1978 Apr; 153(4):283-7. PubMed ID: 25249
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of metiamide, a histamine H2 - receptor antagonist, on the development of gastric stress ulcers and acid secretion.
    Bugajski J; Hano J; Danek L
    Eur J Pharmacol; 1976 Mar; 36(1):237-40. PubMed ID: 1261597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new form of antihistamine--the H2-receptor antagonist.
    Shearman DJ
    Med J Aust; 1976 Jun; 1(26):1005-9. PubMed ID: 10508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy.
    McCarthy DM; Olinger EJ; May RJ; Long BW; Gardner JD
    Ann Intern Med; 1977 Dec; 87(6):668-75. PubMed ID: 22304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Accary JP
    Nouv Presse Med; 1974 Sep; 3(30):1883. PubMed ID: 4154029
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome.
    Stabile BE; Ippoliti AF; Walsh JH; Passaro E
    Am J Surg; 1983 Jan; 145(1):17-23. PubMed ID: 6129812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H2 receptor antagonists.
    Siepler JK; Campagna KD; Donahue PE; Bombeck CT
    Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)].
    Hausamen TU; Fritsch WP; Scholten T; Jungblut R; Strohmeyer G
    Dtsch Med Wochenschr; 1977 Nov; 102(47):1709-12. PubMed ID: 21785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.
    Mainardi M; Maxwell V; Sturdevant RA; Isenberg JI
    N Engl J Med; 1974 Aug; 291(8):373-6. PubMed ID: 4152590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.